Skip to content

Randomized controlled study of proximal subtotal gastrectomy and total gastrectomy resection treatment for advanced adenocarcinoma of the esophagogastric junction (Siewert II)

Randomized controlled study of proximal subtotal gastrectomy and total gastrectomy resection treatment for advanced adenocarcinoma of the esophagogastric junction (Siewert II)

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPC-14005625
Enrollment
Unknown
Registered
2014-12-03
Start date
2014-12-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

adenocarcinoma of esophagogastric junction

Interventions

1:Proximate Gastrectomy
2:Total Gastrectomy

Sponsors

The Affiliated Hospital of North Sichuan Medical College
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Advanced adenocarcinoma of esophagogastric junction (Siewert II); 2) Surgical pointer; 3) Proximal subtotal gastrectomy and total gastrectomy resection treatment is feasible; 4) informed patient.

Exclusion criteria

Exclusion criteria: 1) Adenocarcinoma of esophagogastric junction (Siewert I or III); 2) Only with total gastrectomy to achieve R0 resection.

Design outcomes

Primary

MeasureTime frame
Survival time;Quality of Life;

Secondary

MeasureTime frame
Year recurrence rate after surgery;Mortality after one year;The incidence of postoperative complications;Operative mortality;

Countries

China

Contacts

Public ContactFU Mao-yong
fumaoyongmd@163.com+86 13989186598

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026